Fujifilm击败了收入估计,但降低了2025年的前景,认为医疗保健增长强劲。 Fujifilm beat earnings estimates but lowered 2025 outlook, citing strong healthcare growth.

Fujifilm预测2025年财政收入为每股147美元,收入224亿美元,低于分析人员预计的229亿美元。 Fujifilm projected fiscal 2025 earnings of $1.47 per share and $22.4 billion in revenue, below analyst expectations of $22.9 billion. 该公司报告季度结果强劲,上报了75美元的EPS和53.3亿美元的收入,大大超过估计。 The company reported strong quarterly results, posting $0.75 EPS and $5.33 billion in revenue, significantly exceeding estimates. 保健部门(包括医疗设备、药品和再生医学)推动增长。 Growth is driven by its Healthcare segment, including medical devices, pharmaceuticals, and regenerative medicine. 股票升至11.07美元,贸易额低于平均水平。 Shares rose to $11.07, with trading volume below average. 该公司的市场上限为275.4亿美元,P/E比率为9.97,债务对股本比率为0.17。 The company has a market cap of $27.54 billion, a P/E ratio of 9.97, and a debt-to-equity ratio of 0.17.